Acrivon Therapeutics, Inc. (ACRV) Operating cash flow 2021–2025
Acrivon Therapeutics, Inc. (ACRV) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$63.7MFY2025 · since FY2021: -$14.0M → -$63.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$63.7M | +3.1% |
| FY2024 | -$65.7M | -54.0% |
| FY2023 | -$42.6M | -41.6% |
| FY2022 | -$30.1M | -115.4% |
| FY2021 | -$14.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice